244 participants
IV Bevacizumab Treatment of Patients With Hereditary Hemorrhagic Telangiectasia (HHT) or Rendu-Osler (RO) Disease: A Retrospective Analysis of French Cohort Data From 2009 to 2024
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-19
- Start Date:
- 2009-01-01
- Completion:
- 2024-12-31
Conditions
- Hereditary Hemorrhagic Telangiectasia (HHT)
- Rendu Osler Disease
Interventions
- OTHER
No Results Yet